22 February 2017
News and Views
Links and Services
In a study published ahead of print, the Alimentary Pharmacology & Therapeutics reports on a tool to aid clinicians in practice on aspirin-related cardiovascular and gastrointestinal risk.
Assessment of both gastrointestinal and cardiovascular risks vs. the benefits of low-dose aspirin
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors